Jefferson planning to reduce its payroll

Article Abstract:

The Jefferson Health System announced yesterday that it would like to save money through employee attrition and, maybe, some layoffs. The company's cost-cutting might be the first example of the effect of increasing costs, especially for malpractice insurance premiums and for labor, on the Philadelphia region's health-care industry.

Management consulting services, Administrative Management and General Management Consulting Services, Consulting services, Jefferson Health System Inc.

---

Creditors forego Allegheny claims; they would be paid about $25 million instead in facilitating the sale of four Pittsburgh-area hospitals

Article Abstract:

Creditors of Pennsylvania's bankrupt Allegheny health system have agreed to drop their claims in exchange for about $25 million. The deal will allow Allegheny to finalize the sale of its 4 Pittsburgh-area hospitals to the Western Pennsylvania Healthcare System, according to West Penn CEO Charles M. O'Brien Jr. The 65,000 creditors are owed over $1.5 billion. Officials of the two hospital chains hope to complete the sale by late May 1999.

Comment:

Creditors of Pennsylvania's Allegheny health system have agreed to drop their claims in exchange for about $25 million

Allegheny Health Systems

---

Jefferson to lay off 125, drop 250 jobs

Article Abstract:

Philadelphia, Penn.-based Jefferson University Hospitals, which is facing a deficit of $21 million, has announced 125 job cuts as it seeks to reduce costs. Hospital officials, which report problems such as increased costs of health-care technology and lower rates of payments for health services, have said that the health care network will also eliminate 250 vacant job positions.

Jefferson University Hospitals

Similar abstracts:

• Abstracts: Purchase of Pilgrim Baxter is called off; the Berwyn fund firm and Nationwide fail to agree on a price. Teachers commit to Radnor fund
• Abstracts: Doylestown firm gets U.S. rebuke on its ad claims; Quigley Corp. will stop making certain statements about the health effects of its Cold-Eeze zinc lozenges
• Abstracts: Former Rhone-Poulenc Rorer chief will head ViroPharma; Michel de Rosen says the small Exton pharmaceutical firm is developing antiviral drugs that show promise
• Abstracts: Group helps nonprofits tackle spyware plague: NPower Pennsylvania hosts workshops. Company advises nonprofits on how to use technology

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.